HHealth Read More UCLA experts call for individualized heart monitoring in breast cancer survivorsNovember 5, 2025 As breast cancer survival rates continue to climb – 4.3 million women in the U.S. are currently living…
HHealth Read More Advances in diagnosis and management of systemic light chain amyloidosisOctober 30, 2025 Systemic light chain (AL) amyloidosis is a rare and life-threatening disorder characterized by the deposition of misfolded immunoglobulin…
TTechnology Read More Context-dependent impact of type I interferon signaling in cancer | Molecular CancerOctober 30, 2025 Hardy MP, Owczarek CM, Jermiin LS, Ejdebäck M, Hertzog PJ. Characterization of the type I interferon locus and…
HHealth Read More Lifestyle changes and postmenopausal breast cancer risk in women from the European Prospective Investigation into Cancer and Nutrition | Breast Cancer ResearchOctober 29, 2025 Study population EPIC is a large prospective multicentre study involving 521,323 healthy adults from the general population, aged…
HHealth Read More Assessing the relationship between cardiometabolic diseases and the risk of developing aggressive prostate cancer: a systematic review and meta-analysis | BMC CancerOctober 25, 2025 Summary of findings To the best of our knowledge, this study provides the first comprehensive quantitative synthesis indicating…
TTechnology Read More Mitochondria and lysosomes work together to control regulatory T cell activationOctober 25, 2025 Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the…
GGenetics Read More The MyCancerGene study: a hybrid type 1 effectiveness-implementation randomized study comparing a patient-centered digital genetic health portal to usual care after receipt of cancer genetic testing | BMC CancerOctober 24, 2025 Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K. American society of clinical oncology policy statement update:…
HHealth Read More Study shows mRNA-based COVID vaccines enhance effectiveness of immune checkpoint therapyOctober 22, 2025 Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice…
BBusiness Read More PSMAddition data show Novartis Pluvictoâ„¢ delays progression to end-stage prostate cancerOctober 19, 2025 PluvictoTM plus standard of care (ARPI + ADT) significantly reduced risk of progression or death by 28% (HR…
GGenetics Read More Association of genetic variants in m1A modification core genes and neuroblastoma risk | BMC CancerOctober 18, 2025 Park JR, Kreissman SG, London WB, Naranjo A, Cohn SL, Hogarty MD, et al. Effect of tandem autologous…
HHealth Read More Curcumin in prostate cancer: a systematic review of molecular mechanisms and nanoformulated therapeutic strategies | BMC CancerOctober 18, 2025 Curcumin, a dietary polyphenol derived from Curcuma longa, has been extensively studied for its pleiotropic biological activities, particularly…
GGenetics Read More Reporter’s Notebook: The Overdue Breakout for Gene Therapy and Gene EditingOctober 15, 2025 As gene editing enters a new era, leaders discuss Baby KJ’s implications for families, science, and industry. (Left…